[Usefulness of the Beck depression inventory in the diagnosis of depressive disorders in multiple sclerosis]. [PDF]
Introducción. La depresión es una de las condiciones psiquiátricas con mayor prevalencia en la edad adulta y alcanza cifras alrededor del 20%. Las metodologías para el estudio de la depresión son varias y van del uso de un test autoadministrado a la ...
Aparicio-Castro E +3 more
europepmc +2 more sources
[Periodic plasmapheresis as maintenance treatment in relapsing-remitting multiple sclerosis, a new therapeutic line? A case report]. [PDF]
Introducción. El tratamiento de la esclerosis múltiple remitente-recurrente ha evolucionado significativamente en los últimos años con el descubrimiento de nuevas moléculas eficaces como tratamiento de mantenimiento.
Lafuente-Gómez G +11 more
europepmc +2 more sources
Tratamiento inmunosupresor en pulsos en esclerosis múltiple durante el desescalado de la epidemia por SARS-CoV-2. Algoritmo de seguridad [PDF]
Resumen: Introducción: La pandemia por SARS-CoV-2 está condicionando los abordajes diagnósticos, terapéuticos y asistenciales establecidos en esclerosis múltiple (EM). Durante las fases inicial y pico de la epidemia, los fármacos modificadores del curso
G. Valero-López +10 more
doaj +2 more sources
Objetivo: El objetivo del presente estudio fue evaluar la Calidad de Vida Relacionada con la salud (CVRS) en personas con Esclerosis Múltiple (EM) mediante el cuestionario MSQOL-54 y analizar su relación con la salud de las personas cuidadoras ...
María Dolores Martínez-Espejo +5 more
doaj +2 more sources
Differential distribution of antiviral serology across multiple sclerosis phenotypes and its implications for disease pathogenesis [PDF]
Multiple sclerosis (MS) is a heterogeneous inflammatory disease of the central nervous system in which environmental factors, particularly viral infections, are thought to contribute to disease susceptibility and progression.
Dominguez-Mozo Maria Inmaculada +15 more
doaj +2 more sources
HERV-W association with serum biomarkers NfL and GFAP in multiple sclerosis [PDF]
BackgroundSerum biomarkers of multiple sclerosis (MS), such as glial fibrillary acidic protein (sGFAP) and neurofilament light chain (sNfL), are established indicators of disease progression and disability.
Stefano Ruberto +11 more
doaj +2 more sources
The global lockdown measures implemented due to the COVID-19 pandemic have nearly always had negative consequences for patients with multiple sclerosis (MS). Objective: We compared the social and professional effects of confinement on patients with MS in
G.-X. Zhang +9 more
doaj +1 more source
Fe de errores a “Tratamiento inmunosupresor en pulsos en esclerosis múltiple durante el desescalado de la epidemia por SARS-CoV-2. Algoritmo de seguridad” [Neurologia. 2020;35(6):357–362] [PDF]
G. Valero-López +10 more
doaj +2 more sources
Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders
Introduction: Neuromyelitis optica spectrum disorders (NMOSD) are immune-mediated inflammatory disorders of the central nervous system involving astrocytes, B lymphocytes, anti-aquaporin 4, and such inflammatory mediators as interleukin-6.
E. Carreón Guarnizo +7 more
doaj +1 more source
Effect of visual biofeedback cycling training on gait in patients with multiple sclerosis
Introduction: Gait alterations are present in a high percentage of patients with multiple sclerosis (MS). They appear from early stages of the disease and can limit patients’ capacity to perform basic activities of daily living, affecting their quality ...
A. Hochsprung +4 more
doaj +1 more source

